|
Date |
Title |
|---|---|
|
11.12.2013 |
Switzerland Global Enterprise Event 2013, Bern, Switzerland |
|
21.11.2013 |
Swissmedforum 21.11.2013, Zurich, Switzerland |
|
24.10.2013 |
8.Wirtschaftsforum Kt.Schwyz, Switzerland |
|
23.10.2013 |
EFC Venture Contest 23./24. October 2013, Aarhus, Denmark |
| 15.10.2013 |
Launch DnBiomed, Spain |
| 05.09.2013 |
EFVF European Food Venture Forum 05.-06. September 2013, Aarhus, Denmark |
|
12.02.2013 |
7th Swiss-Scandinavian Bio-Business Seminar, Zurich, CH |
| 05.02.2013 |
Sales preparations USA, Begin 1st September 2013 |
| 01.02.2013 |
Start WeLoxx campain at indiegogo, CA, USA |
|
24.10.2012 |
EVC Aarhus, Semi-Final European Venture Contest, HealthCare, presentation, Aarhus, DK |
| 25.09.2012 | World Medtech Forum, Lucerne, CH |
|
20.09.2012 |
BioSpain 2012 Meeting Biotechnology, presentation, Bilbao, ES |
| 04.07.2012 | SEF-Swiss Start-Up Award, Zurich |
| 19.03.2012 | 3rd pat.pend. preceded by the 1st CH684982 patent; 2nd CH701039 (A2); PCT-WO2012-xxxxxxxxx pat.pend. |
| 21.11.2011 | Clinical-trials.gov; NCT00407420 (Bristol Royal Hospital,UK)/ (Dr. Per Sodersten, PhD, Karolinska Institutet, Stockholm; FDA clearance |
| 17.08.2011 | Internet presence |
| 15.11.2010 | 2nd pat.pend. preceded by the 1st CH684982 patent; CH701039 (A2); PCT-WO2009-xxxxxxxxx pat.pend. |
| 01.11.2010 | Venturekick & Venturelab 2010 planning and training stages |
| 20.06.2010 | Marketing and PR concept created by Partner Company, May / June 201 |
| 15.06.2010 | 10 fully functional products available which are in test use since June 2010 |
| 01.01.2009 | Business and personal preparations; project design, realizations, development and strategy |
| 01.01.2008 | Start and business dispositions of "Erib Corp." |
|